Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Resistant Psoriasis
IRCT20120524009844N8Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jul 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, single-arm trial of adalimumab in psoriasis, sponsored by Tabriz University of Medical Sciences. Started Jul 2020; status: completed.
02
Drugs
03
Conditions
psoriasis
Beyond the preview
Go deeper on IRCT20120524009844N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120524009844N8.